Raloxifene and Cardiovascular Events in Osteoporotic Postmenopausal Women: Four-Year Results From the MORE (Multiple Outcomes of Raloxifene Evaluation) Randomized Trial

CONTEXT Raloxifene, a selective estrogen receptor modulator, improves cardiovascular risk factors, but its effect on cardiovascular events is unknown. OBJECTIVE To determine the effect of raloxifene on cardiovascular events in osteoporotic postmenopausal women. DESIGN Secondary analysis of data from...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA : the journal of the American Medical Association 2002-02, Vol.287 (7), p.847-857
Hauptverfasser:	Barrett-Connor, Elizabeth, Grady, Deborah, Sashegyi, Andreas, Anderson, Pamela W, Cox, David A, Hoszowski, Krzysztof, Rautaharju, Pentti, Harper, Kristine D, for the MORE Investigators
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biological and medical sciences Cardiovascular disease Cardiovascular Diseases - epidemiology Cardiovascular system Clinical trials Double-Blind Method Estrogens Female Health risk assessment Humans Ischemic Attack, Transient - epidemiology Lipoproteins - blood Medical sciences Miscellaneous Myocardial Ischemia - epidemiology Osteoporosis, Postmenopausal - drug therapy Pharmacology. Drug treatments Raloxifene Hydrochloride - therapeutic use Risk Assessment Selective Estrogen Receptor Modulators - therapeutic use Stroke - epidemiology Survival Analysis Women
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!